Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central nervous system infections in injection drug users.

Allan R Tunkel1, Sandeep K Pradhan

  • 1Division of Infectious Diseases, MCP Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA. allan.tunkel@drexel.edu

Infectious Disease Clinics of North America
|October 10, 2002
PubMed
Summary

Central nervous system infections and toxin-mediated diseases pose severe risks for injection drug users. Prompt diagnosis and treatment, including antimicrobial and surgical interventions, are crucial for managing these serious neurological complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benefits, Challenges, and Opportunities of LCME Accreditation: A National Survey.

Medical science educator·2026
Same author

Perspectives in Brain Abscess Diagnosis and Management: A National Survey of Infectious Disease Specialists.

Open forum infectious diseases·2025
Same author

Maintenance of Certification: Is a Knowledge-Based Assessment Really Necessary?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

United States Medical Licensing Examination Performance and Outcomes of Patient Care.

Academic medicine : journal of the Association of American Medical Colleges·2024
Same author

Cefazolin for the Treatment of Central Nervous System Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2023
Same author

Perspectives on Diagnosis and Management of All-Cause Encephalitis: A National Survey of Adult Infectious Diseases Physicians.

Open forum infectious diseases·2023

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Injection drug use is associated with a high burden of central nervous system (CNS) infections and toxin-mediated diseases.
  • Infective endocarditis in this population can lead to severe neurological sequelae like cerebral infarction, intracranial hemorrhage, and brain abscess due to embolization.
  • Focal CNS infections can also arise from bacteremia seeding the brain or epidural space, independent of endocarditis.

Purpose of the Study:

  • To highlight the spectrum of CNS infections and toxin-mediated diseases in injection drug users.
  • To emphasize the importance of clinical suspicion for diagnosing these conditions.
  • To underscore the necessity of timely and appropriate therapeutic interventions.

Main Methods:

Related Experiment Videos

  • Review of clinical presentations and outcomes of CNS infections in injection drug users.
  • Discussion of diagnostic challenges and therapeutic strategies.
  • Emphasis on recognizing toxin-mediated diseases such as tetanus and wound botulism.
  • Main Results:

    • Central nervous system infections, including brain abscess and spinal epidural abscess, are significant complications.
    • Embolic events from infective endocarditis frequently cause cerebral infarction and hemorrhage.
    • Toxin-mediated diseases, like tetanus and wound botulism, result from Clostridium species inoculation at injection sites.

    Conclusions:

    • Effective management of neurological complications requires a combination of antimicrobial therapy and surgical intervention.
    • Clinicians must maintain a high index of suspicion for CNS infections and toxin-mediated diseases in injection drug users.
    • Early diagnosis and treatment are critical to improve patient outcomes and reduce mortality.